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Alcohol and nicotine are two of the most frequently abused drugs, with their comorbidity
well described. Previous data show that chronic exposure to nicotine upregulates high-
affinity nicotinic acetylcholine receptors (nAChRs) in several brain areas. Effects of
ethanol on specific brain nAChR subtypes within the mesolimbic dopaminergic (DA)
pathway may be a key element in the comorbidity of ethanol and nicotine. However, it is
unknown how alcohol affects the abundance of these receptor proteins. In the present
study, we measured the effect of acute binge ethanol on nAChR α4 subunit levels in the
prefrontal cortex (PFC), nucleus accumbens (NAc), ventral tegmental area (VTA), and
amygdala (Amg) by western blot analysis using a knock-in mouse line, generated with a
normally functioning α4 nAChR subunit tagged with yellow fluorescent protein (YFP). We
observed a robust increase in α4-YFP subunit levels in the NAc and the Amg following
acute ethanol, with no changes in the PFC and VTA. To further investigate whether
this upregulation was mediated by increased local mRNA transcription, we quantified
mRNA levels of the Chrna4 gene using qRT-PCR. We found no effect of ethanol on α4
mRNA expression, suggesting that the upregulation of α4 protein rather occurs post-
translationally. The quantitative counting of YFP immunoreactive puncta further revealed
that α4-YFP protein is upregulated in presynaptic boutons of the dopaminergic axons
projecting to the shell and the core regions of the NAc as well as to the basolateral
amygdala (BLA), but not to the central or lateral Amg. Together, our results demonstrate
that a single exposure to binge ethanol upregulates level of synaptic α4∗ nAChRs in
dopaminergic inputs to the NAc and BLA. This upregulation could be linked to the
functional dysregulation of dopaminergic signalling observed during the development
of alcohol dependence.
Keywords: alcohol, nicotinic receptor, dopamine, nucleus accumbens, amygdala
Abbreviations: Amg, amygdala; AUDs, alcohol use disorders; BEC, blood ethanol concentration; BLA, basolateral amygdala;
CeA, central amygdala; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GFP, green fluorescent protein; HPA,
hypothalamic-pituitary-axis; HPRT, hypoxanthine-guanine phosphoribosyltransferase; LA, lateral amygdala; LORR, Loss
of righting reflex; NAc, nucleus accumbens; nAChR, nicotinic acetylcholine receptor; PFC, prefrontal cortex; qRT-PCR,
quantitative reverse transcription polymerase chain reaction; RORR, return of righting reflex; TH, Tyrosine hydroxylase;
VTA, ventral tegmental area; YFP, yellow fluorescent protein
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INTRODUCTION
Binge drinking is the most common pattern of excessive
alcohol intake and is the leading cause of death and disability
globally among people between the ages of 15–49 (Lim et al.,
2012). Alcohol (ethanol) in relevant concentrations functionally
interferes with the release of several brain neurotransmitters,
including dopamine (Bainton et al., 2000; Doyon et al., 2003),
and acetylcholine, as well as their respective receptors (Larsson
et al., 2005), on both activation and desensitisation. Although
extensive research has examined the role of nicotinic receptors in
nicotine addiction, alcohol-related changes in neuronal nAChRs
involved in AUDs remain unclear. These nAChRs belong to a
super-family of ligand-gated ion channel receptors, which when
activated, allow for the flux of several cations. They are localised
both pre- and post-synaptically and cause calcium dependent
signalling cascades in many neuronal cell types (Albuquerque
et al., 2009). Indeed, identification of changes in nAChRs brought
about by alcohol may help to improve pharmacotherapies for
alcohol dependence.
The limbic system includes several pathways between the
hypothalamic-pituitary-adrenal (HPA) axis and dopaminergic
systems, encompassing the PFC, NAc, VTA and the amygdala
(Amg). This includes the mesocorticolimbic dopaminergic or
‘reward’ pathway, which is involved in the addiction to many
drugs of abuse (Koob and Volkow, 2016). These regions are
intimately connected. The NAc receives inputs from the BLA,
sending outputs to the basal ganglia and ventral pallidum (Yager
et al., 2015). Both receive dopaminergic innervation from the
VTA. In the reward pathway (humans and rodents alike),
the PFC is thought to be involved in monitoring information
regarding choice, and the adjustment of behaviour in response
to consequences (St Onge and Floresco, 2010), in turn, the
amygdala and NAc play a role in representing the value of the
reward (Mendez et al., 2013). Determining how substances of
abuse such as ethanol affect nAChRs in these regions is essential
to understanding how these drugs regulate reward processes
and modulate decision-making and risky behaviour that further
contribute to the development of alcohol dependence.
Few studies have investigated ethanol-induced changes in
nicotinic receptor expression at the mRNA or protein level,
and it remains an area of significance in understanding alcohol
dependence. The impact of ethanol on the expression of specific
nAChR subunits has mostly been investigated using heterologous
systems, such as cell lines expressing nAChR subtypes. However,
the mechanisms of ethanol-induced changes in nAChRs in vivo
may differ from those in heterologous expression systems.
Despite this, genetic analysis and manipulations point to the
involvement of α4∗ nAChRs (where α4∗ denotes that other
subunits are present in the heteropentameric nAChR protein)
in alcohol addiction (Butt et al., 2003; Coon et al., 2014).
The α4 subunit is the most widely expressed α subunit in the
mammalian brain, including dopaminergic projection areas such
as the NAc and amygdala, representing principal relay stations
in the extended amygdala circuit (Exley and Cragg, 2008).
Most studies agree that in the case of nicotine, alterations in
presynaptic α4∗ nAChRs on dopaminergic neurons mediates key
pathways involved in reward (Lena et al., 1999; Zhou et al., 2001;
McGranahan et al., 2011), and in line with this, the partial α4β2
agonist varenicline enhances dopamine (DA) release in the NAc
(Feduccia et al., 2014). Little is known about the response of this
receptor subtype to ethanol, however, as in contrast to nicotine,
ethanol acts primarily to potentiate the response of nAChRs to
acetylcholine (ACh) rather than as a direct agonist (Zuo et al.,
2002).
Although available evidence shows that transcription and
upregulated protein synthesis is not directly involved in
nicotine-induced increases in α4∗ nAChRs (Pauly et al., 1996;
Miao et al., 1998; Huang and Winzer-Serhan, 2006), ethanol
regulation of heteromeric nAChRs is still widely unresolved.
Until recently, in vivo studies concerning nAChR subunits
have been hindered by the lack of selectivity of receptor-
specific antibodies. Indeed, several studies have concluded that
under commonly used conditions, nAChR antibodies are not
suitable for immunocytochemistry (Herber et al., 2004; Jones
and Wonnacott, 2005; Moser et al., 2007). An advance has
been the generation of transgenic knock-in mice in which the
nAChR subunit is fused with YFP (Nashmi et al., 2007), and
these have previously been used to successfully quantitate α4
subunit expression in the brain (Chatterjee et al., 2013; Renda and
Nashmi, 2014).
Using these knock-in mice, we examine the effect of acute
ethanol exposure on nAChRs containing the α4 subunit by
western blot and on the gene encoding for the subunit (Chrna4)
by real-time PCR (qPCR) in brain regions involved in the
mesocortical limbic reward pathway, in particular the PFC,
NAc, VTA and amygdala. We further adapted a quantitative
immunohistochemistry method to determine the micron-scale
localisation of any changes. Given the prominent role of
dopaminergic signalling within the NAc and amygdala in the
effect of alcohol, we investigated whether α4 subunit expression
within the presynaptic boutons of dopaminergic fibres was
modulated by binge ethanol exposure. Our results indicate that
a single exposure to a sedating dose of ethanol upregulates the
expression of synaptic α4∗-receptors in dopaminergic inputs to
the NAc and BLA, directly linking alcohol to the functional
dysregulations of dopaminergic signalling observed during the
development of alcohol dependence.
MATERIALS AND METHODS
Animals and Housing
The α4 nAChR YFP knock-in mice were produced by replacing
exon 5 of the mus musculus Chrna4 gene. The WT exon was
replaced with an exon tagged with a YFP in the intracellular
M3-M4 intracellular loop, allowing for functional fluorescently
labelled α4 nAChR subunits. The tagged α4∗ nAChRs display
similar localisation patterns in the brain and are under the control
of the same promoters, enhancers, and trafficking mechanisms
as their WT littermates (Nashmi et al., 2007). These mice were
backcrossed on a C57BL/6J strain for ≥ 10 generations. We
studied male α4-YFP mice born from heterozygous breeding
pairs, with genotyping performed using PCR as previously
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described (Nashmi et al., 2007). All transgenic mice used were
healthy and normal in their weight, appearance and showed no
obvious signs of physical or neurobiological deficits. Mice used
for this study were bred and housed in standard ventilated cages
in climate-controlled rooms. Food, water, and environmental
enrichment were available ad libitum. This study was carried
out in accordance with the recommendations of National Health
and Medical Research Council (NHMRC) guidelines to promote
the well-being of animals used for scientific purposes and the
Australian code for the care and use of animals for scientific
purposes. The protocol was approved by the Queensland
University of Technology Animal Ethics Committee and the
University of Queensland Animal Ethics Committee.
Drugs and Chemicals
For the systemic injections, ethanol (100% v/v, ThermoFisher
Scientific, Hanover Park, IL, United States) was administered in
a volume of 1 ml/kg of ethanol (20%, 3.6 g/kg, 20 ml/kg, i.p.) or
saline (NaCl 0.9% w/v, 20 ml/kg, i.p.).
Acute Ethanol Exposure
At the commencement of the experiment, 8–10 week old
α4-YFP males were separated into treatment and control
groups. Mice were weighed, and a large acute dose of 3.6 g/kg
ethanol [20 mL/kg, 20% (v/v) ethanol] was administered
intraperitoneally. Control was 0.9% saline administered at
20 ml/kg. The LORR and RORR were measured as previously
described by Ponomarev and Crabbe (2002). Twenty-four
hours post-treatment mice were deeply anaesthetised with
isoflurane, and brains removed post-cervical dislocation and
rapid decapitation. 1 mm coronal sections were made using
an ice cold brain matrix (Australian National University) with
section(s) containing brain regions of interest placed on an ice-
cold platform and dissected under a microscope (Leica S6D,
Buffalo Grove, IL, United States) according to visual anatomical
landmarks and the atlas of Paxinos and Franklin. Brain tissue was
snap frozen in RNase and DNase free tubes and stored at −80◦C
until processing.
Blood Ethanol Concentration
Blood ethanol concentrations were tested at 30 min following
ethanol exposure. Tail blood samples were collected in tubes
containing EDTA. The assay was performed on EDTA plasma
using the nicotinamide adenine dinucleotide (NAD)-ethanol
dehydrogenase (ADH) spectrophotometric assay (Kristoffersen
et al., 2005). All reagents used in this assay were purchased from
Sigma-Aldrich (St. Louis, MO, United States). All samples and
standards were run in triplicate, with BECs measured against a
standard calibration curve.
Measurement of α4 Subunit nAChR
Levels by Western Blot
Appropriate volumes of cold lysis buffer – phosphate buffered
saline (PBS) containing 0.1% Triton-X and protease inhibitor
(Thermo Fisher Scientific, Crystal Lake, IL, United States)
were added to samples on ice, and homogenised using 0.5 mm
glass beads. Samples were centrifuged, with supernatant
plus appropriate standards (Albumin Standard, Thermo
Fisher Scientific, Crystal Lake, IL, United States) loaded
onto a 96-well plate in triplicate with Bradford reagent
(Bio-Rad, CA, cat). Absorbance was measured at 595 nm
and protein level determined from the standard curve.
Remaining supernatant was prepared for electrophoresis to
a concentration of 30 µg/lane with laemmli sample buffer
(Bio-Rad, United States) containing dithiothreitol (DTT) and
incubated at 37◦C.
Proteins were separated using sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS–PAGE) using 4-
20% pre-cast Tris-glycine gels (Bio-Rad, United States) and
blotted to a polyvinylidene fluoride (PVDF) membrane in
transfer buffer containing 20% methanol. Protein migration
was assessed relative to the migration of Precision Plus
ProteinTM dual colour standard (10–250 kDa). Membranes
were washed (1 × 20 min, 2 × 10 min) and then blocked
using 5% dry milk solution in 0.05% Tween 20 in PBS.
Post-blocking, blots were probed overnight with monoclonal
mouse anti-GAPDH antibody (1:15000, Thermo Fisher
Scientific, Crystal Lake, IL, United States), mouse monoclonal
anti-GFP antibody to detect YFP (1:500, Cell Signaling
Technologies, Danvers, MA, United States) and mouse anti-
TH (Millipore #MAB318, 1:10000) in the blocking solution.
Washing was repeated, and membranes developed with
donkey anti-mouse IgG (H&L) tagged with DyLightTM 800
(1:1000, Rockland, PA, United States) for 1 h at RT in
0.05% Tween 20/PBS. Membranes were washed, then dried
out at 4◦C using desiccant beads. Bands of interest were
visualised using the Odyssey infrared imager (LI-COR
Biosciences, Lincoln, NE, United States) and band densities
(K counts) quantified using the Odyssey 2.0.40 software
(LI-COR).
Measurement of α4 Subunit nAChR
Levels by Quantitative
Immunohistochemistry
Histology
Twenty-four hours after ethanol injection, animals were
transcardially perfused with 4% paraformaldehyde (PFA) prior
to decapitation. Brains were harvested and post-fixed overnight
at 4◦C. Thirty-micron thick coronal vibratome sections were
collected and immersed in ice-cold 10% methanol-PBS solution
for 5 min. After three washes in citrate buffer solution (10 mM
citrate buffer, 0.05% Tween 20, pH 6.0) at room temperature,
sections were incubated in a 37◦C pre-heated citrate buffer
solution and placed at 80◦C for 20 min for antigen retrieval,
rinsed 3 times in PBS and incubated overnight in blocking
solution (3% bovine serum albumin BSA, 0.3% Triton and 0.05%
Tween 20).
Immunohistochemistry
Sections containing the NAc (Bregma 1.70 to 0.90 mm) or
the amygdala (Bregma −1.40 to −2.00 mm) were incubated
overnight at 4◦C with primary antibodies diluted in the blocking
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solution: rabbit anti-GFP (Abcam #290, 1:5000) and mouse anti-
TH (Millipore #MAB318, 1:500) and, after three washes in the
blocking solution, incubated with secondary antibodies diluted
in the blocking solution overnight at 4◦C: donkey anti-rabbit-
Alexa 488 and donkey anti-mouse-Alexa 647 (Thermofisher
Scientific, 1:500). Sections were mounted in Prolong Gold
antifade mountant (Thermofisher Scientific). For synaptic α4-
YFP puncta detection, sections were incubated overnight at room
temperature with mouse anti-synaptophysin antibody (Sigma
#S5768, 1:200), followed by 4h incubation with goat anti-mouse
monovalent Fab-Alexa 647 (Jackson #115607003, 1:500). Free
mouse epitopes were blocked with anti-mouse unconjugated
monovalent Fab antibodies (Abcam #ab6668, 1:100) overnight
at 4◦C. GFP and TH immunolabelling were conducted as above
with goat-raised secondary antibodies (Thermofisher Scientific,
1:500).
Imaging and Analysis
Three sections per animal (n = 5–6 animals/group, 15–18
images/brain region/group) were imaged on an Olympus FV1200
confocal microscope using a 60X oil-immersion objective (NA
1.35) with 2.5 × zoom, with a Z-axis step of 0.3 µm. Images
were deconvolved using Huygens Professional v16.10 (Scientific
Volume Imaging) with 100 iterations, quality threshold at 0.001,
signal to noise ratio at 15 for the three channels. Images were
subsequently analysed in Imaris 8.2.1 (Bitplane), as previously
described (Belmer et al., 2017). Total YFP punctate fluorescence
(α4-YFP) (Figure 1A) was quantified using the spot detection
function of Imaris, with a spot diameter of 0.4 µm (Figure 1B).
TH immunolabelled fibres (Figure 1C) were reconstructed in
3D using the surface rendering function (Figures 1E,F). The
YFP punctate fluorescence within TH reconstructed fibres (α4-
YFPTH+), was isolated using the masking function and quantified
using the spot detection function (Figure 1D). The spot
colocation function was used to identify and quantify the synaptic
YFP punctate fluorescence co-localised with synaptophysin
puncta within TH reconstructed fibres (α4-YFPSYN/TH+; n = 5–
6 animals/group, 15 images/brain region/group). The density
of α4-YFP puncta or TH immunolabelled fibres was calculated
per µm3 of tissue, and the density of α4-YFPTH+ puncta
(Figures 1E,F) calculated per µm3 of TH immunoreactive fibres.
The proportion of α4-YFPTH+ puncta (α4-YFPSYN/TH+) was
calculated in percent of total α4-YFPTH+.
Measurement of Chrna4 mRNA Level
Using qRT-PCR
Prior to RNA extraction, RNAlater R© was added to the samples at
10× the volume of tissue and incubated at−20◦C for a minimum
of 16 h. Total RNA extraction was then performed using the
RNeasy R© micro kit (Qiagen, Hilden, GER) as per manufacturer’s
instructions. RNA concentration and purity were assessed using
the NanoDropTM 1000 UV-Vis spectrophotometer. For removal
of contaminant DNA, 500 ng of total RNA was treated with
DNase I, amplification grade (1 U; 10 µL total volume). First
strand synthesis was carried out using the SuperScript R© III First-
Strand Synthesis System for qRT-PCR as per the manufacturer’s
instructions. For qRT-PCR, cDNA (equivalent of 500 ng RNA
FIGURE 1 | Illustration of the quantitative immunohistochemistry method used
to determine α4YFP levels. (A–F) Representative images taken from the CeA
of saline treated mice. (A) Micrographs representing the immunolabelling of
α4-YFP (GFP, green; scale bar: 10 µm). (B) Reconstruction of α4 puncta from
α4-YFP labelling (scale bar: 10 µm). Top right box represents a higher
magnification of the dashed square (scale bar: 4 µm). (C) Double
immunolabelling of α4-YFP puncta (GFP, green) and dopaminergic fibres (TH,
red; scale bar: 10 µm). (D) Isolation of α4-YFP puncta (GFP, green) located
within dopaminergic fibres (scale bar: 10 µm). Top left box represents a higher
magnification of the dashed square (scale bar: 7 µm). In (C,D), arrow heads
show examples of α4-YFP puncta in TH fibres. (E) 3D-reconstruction of
α4-YFP puncta (GFP, green) within dopaminergic fibres and dopaminergic
fibres (TH, red; scale bar: 10 µm). (F) Higher magnification of the dashed
square in E, showing α4YFP puncta within dopaminergic fibres (GFP, green),
and dopaminergic fibres (TH, red; scale bar: 2 µm).
starting material) was diluted 1/10 in nuclease-free water. To 2µL
diluted cDNA was added SYBR R© Green Real-Time PCR Master
Mix (1 × final concentration), and forward and reverse primer
(10 nM each) to a final volume of 10 µL. Primers for GAPDH and
HPRT were used as normalisation controls. Primer sequences are
detailed in Table 1. Reactions were conducted in the ViiATM 7
(Applied Biosystem, Foster, CA, United States) Real-Time PCR
System with the following series of thermocycling steps: 95◦C,
10 min; 40× cycles of 95◦C, 15 s; and 63◦C, 10 min. After each
PCR reaction, the specificity of the amplification was evaluated
by a melt curve analysis, and plates controlled for genomic DNA
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TABLE 1 | Nucleotide sequences of PCR and qRT-PCR primers.
Accession No. Target Forward Reverse Amplicon
Genotyping
α4XFP2 F, 5′-CAACCGCATGGACAC
AGCAGTCGAGAC-3′
M, 5′-GCACAAGCTGGAGTA
CAACTACAACAGC-3′
5′-CTCAGTCAGGGAA
GCAGCTCCATCTTG-3′
542
qRT-PCR
NM_015730.5 Chrna4 5′-ACTTCTCGGTGAAG GAGGACT-3′ 5′-GCCCAGAAGGCAG ACAATGAT-3′ 89
NM_001289726.1 GAPDH (Beckley
et al., 2016)
5′-CGACTTCAACAGCA
ACTCCCACTCTTCC-3′
5′-TGGGTGGTCCAGGG
TTTCTTACTCCTT-3′
175
NM_013556.2 HPRT 5′-TCCCAGCGTCGTG ATTAGCGATGA-3′ 5′-AATGTGATGGCCTC
CCATCTCCTTCATGACAT-3′
172
contamination using controls omitting the cDNA template and
the reverse transcriptase step, respectively. Primer dimers were
ruled out using end point PCR, with band specificity checked
by agarose gel electrophoresis. Amplification of GAPDH was
measured in some –RT controls, this was considered negligible
at <0.01% of cDNA amplified. All reagents used in this assay
unless specified were purchased from Thermo Fisher Scientific
(Crystal Lake, IL, United States). For gene primer sets (from
Invitrogen, United States) see Table 1. Correction for sample-
sample variation was done by simultaneously amplifying both
GAPDH and HPRT as a reference. Specific PCR amplification
efficiencies for each gene were generated individually for each
brain region tested using a 7 point Ct (cycle threshold) slope
method, with calibration curves covering a 3-log range with
twofold serial dilutions of cDNA transcript. The Ct values of each
sample were normalised with the mean Ct value for the internal
reference genes and were corrected for the PCR efficiency of each
assay.
Statistics
Statistical analyses were carried out using GraphPad Prism
7 (Graph Pad Software Co., San Diego, CA, United States).
Statistical comparisons for western blot analysis were performed
using a two-tailed unpaired t-test, with Holm-Sidak’s correction
for multiple comparison, and two-way ANOVA with Sidak’s
multiple comparison (without including the PFC due to large
standard deviation of the dataset, see details in the results
section). A p-value < 0.05 was considered significant, with all
values expressed as the mean ± SEM. Real-time qPCR data
were analyzed using the 211Ct method (Pfaﬄ, 2001). Each
data point represents an average of three technical replicates,
with two-way ANOVA analysis followed by Sidak’s comparison,
performed with linear delta Ct values prior to transformation.
One sample showed marked degradation across all primer
sets and was excluded from analysis. A p-value < 0.05 was
considered significant, with biological significance achieved at a
twofold change in expression. The volumetric density of α4-YFP
puncta, TH fibres, α4-YFPTH+ and α4-YFPSYN/TH+ puncta
were analysed by two-tailed unpaired t-test or two-way ANOVA
followed by Sidak’s multiple comparison test. A p-value < 0.05
was considered significant, with all values expressed as the
mean± SEM.
RESULTS
We examined the effect of an acute large dose of ethanol (3.6 g/kg,
i.p.) or saline (20 ml/kg, i.p) on the animal’s LORR and RORR in
order to measure the sedative effect of ethanol in each animal.
Latency to and duration of LORR was analogous to that of
similarly treated C57BL/6 mice (Figures 2B,C). In agreement
with previous studies, the α4-YFP mice, showed no physiological
alterations compared to their WT littermates (Nashmi et al., 2003,
2007; Santos et al., 2013). BECs were also measured to confirm
treatment (Figure 2A).
Acute Exposure to Ethanol Up-regulates
α4 Subunit in the NAc and Amygdala
Levels of α4-YFP protein in the NAc, amygdala, VTA and PFC
were measured 24 h post-ethanol or saline treatment using
a homogenate western blot procedure. Band densities were
measured as integrated intensity (k counts) and quantified as
a percent (%) of GAPDH. Ethanol administration significantly
increased α4YFP protein levels in both the NAc (44.84 ± 7.03
k counts, n = 8, Figure 3A) and the amygdala (35.49 ± 5.43
k counts, n = 8, Figure 3B) compared to the control mice
(20.62 ± 3.70 k counts, n = 8 and 20.19 ± 3.14 k counts, n = 7,
respectively) using a two-tailed unpaired t-test with Bonferroni-
Sidak’s correction for multiple comparison, ∗p = 0.034 (NAc)
and ∗p = 0.037 (Amg). Interestingly, no effect was seen
in the VTA (28.86 ± 5.398 k counts, n = 4, Figure 3C),
or the PFC (72.46 ± 13.45 k counts, n = 8, Figure 3D),
compared to the control mice (30.73 ± 3.627, n = 4 and
47.51 ± 16.24, n = 7, respectively), suggesting that increases
in α4 protein levels may only occur in specific brain regions.
Using two-way ANOVA, we observed significant effect of ethanol
treatment F(1,33) = 9.69, ∗∗p = 0.004, with Sidak’s comparison
showing a significant effect of ethanol treatment in the NAc
(∗∗p = 0.003) and the Amg (∗p = 0.027), with no effect in
the VTA (p = 0.99). PFC was not included in the analysis
due to a large standard deviation, compared to NAc, Amg
and VTA. This large standard deviation is likely due to a
high heterogeneity of both the cholinergic/dopaminergic neurons
within the different layers of the medial vs. infralimbic prefrontal
cortices (Zhang et al., 2010). Treatment with ethanol did not
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FIGURE 2 | Sensitivity to ethanol in α4-YFP-KI mice. (A) Blood ethanol concentrations following a single sedating dose of ethanol. Data are presented as mean
ethanol concentration in mg per dL ± SEM. (B,C) The latency to, and duration of the sedative effects of ethanol show no differences between C57Bl6 and α4-YFP
mice. Data are presented as mean latency to LORR in min ± SEM (B), and duration of LORR in min ± SEM (C); p = 0.95 and p = 0.63, respectively.
FIGURE 3 | Acute ethanol exposure significantly increases levels of α4 subunit in the nucleus accumbens and amygdala but not in the ventral tegmental area and
prefrontal cortex. (A,B) The level of YFP was quantified 20–22 h post-ethanol exposure using western Blot analysis. Data are presented as mean k counts for YFP
expressed as a percentage of GAPDH k counts ± SEM (two-tailed unpaired t-test with Bonferroni-Sidak’s correction for multiple analysis (A) NAc ∗p = 0.034, n = 8;
(B) Amg ∗p = 0.037, n = 7–8; (C) VTA: p = 0.99, n = 4; and (D) PFC: p = 0.69, n = 7–8). Representative western blots showing the level of YFP and GAPDH
expression of both saline (S) and ethanol (E) administered α4-YFP mice are shown for each brain region below the corresponding graphs.
affect the expression of TH in either the NAc or amygdala
(Supplementary Figures S1a,b).
Effect of Acute Ethanol Administration
on the Expression of α4 Subunits within
the Mesocortical Limbic System Is Not
Mediated by Changes in Chrna4 mRNA
Level
Although changes in mRNA expression do not accompany
increased expression of heteromeric nAChRs caused by nicotine,
ethanol has a quite different pharmacology, and alters the mRNA
profiles of similar ligand-gated receptors, such as NMDA and
GABAA receptor subunit genes (Mhatre and Ticku, 1992; Xiang
et al., 2015). To test whether increases in receptor protein are
partly due to increases in gene expression, mRNA primers were
generated to detect α4 subunit mRNAs in brain tissue from
male α4-YFP mice. Regions with high levels of α4-YFP mRNA
expressions were also those with high levels of baseline expression
in western blot analysis. To determine whether the ethanol-
induced up-regulation of α4-YFP levels represented an increase
in production in mRNA, brains were processed for quantitative
analysis by reverse transcriptase PCR. Compared to the brain
region-specific controls, mRNA expression was not significantly
altered 24 h after ethanol treatment (two-way ANOVA, [alcohol
treatment]: F(1,36) = 0.1197, p= 0.73; followed by Sidak’s post hoc
comparison: p> 0.05, Figure 4 and Table 2).
Acute Ethanol Administration
Upregulates the Expression of α4
Subunits in Dopaminergic Fibres within
the NAc Core and Shell and the BLA
The upregulation of nAChRs by nicotine is selective in several
respects but usually involves α4∗ nAChRs, and the α4∗ nAChRs
of dopaminergic nerves are among those upregulated (see
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FIGURE 4 | Chrna4 levels following acute ethanol exposure are not altered in the nucleus accumbens, amygdala, ventral tegmental area and prefrontal cortex.
(A) Change in Ct was normalised against controls GAPDH and HPRT and analysed using two-way ANOVA followed by Sidak’s post hoc analysis on linear delta Ct
values prior to transformation; see Table 2 for detailed statistical analysis. (B) Values were then corrected for the individual PCR efficiency of each brain region using
a 7-point curve represented as a fold-change from control (saline-treated) mice values (1.0). No biological significance was seen, with no brain region exhibiting a
twofold change in expression compared to control. Data are presented as mean ± SEM.
TABLE 2 | Region specific mRNA ratios.
Brain region Efficiency 1Ct Control (n) 1Ct Ethanol (n) Sidak’s test 211Ct
Amygdala Chrna4
GAPDH
HPRT
2.10
2.03
1.94
−5.487 ± 0.11 (6) −5.675 ± 0.24 (6) NS: p = 0.99 0.93 ± 0.13
(p = 0.98)
Nucleus accumbens Chrna4
GAPDH
HPRT
2.20
2.09
1.93
−5.860 ± 0.10 (6) −5.608 ± 0.26 (6) NS: p = 0.35 1.35 ± 0.31
(p = 0.35)
Ventral tegmental area Chrna4
GAPDH
HPRT
2.29
2.36
2.24
−4.620 ± 0.06 (4) −4.508 ± 0.11 (4) NS: p = 0.99 1.10 ± 0.06
(p > 0.99)
Prefrontal cortex Chrna4
GAPDH
HPRT
2.09
2.08
1.97
−4.651 ± 0.10 (5) −4.418 ± 0.08 (5) NS: p = 0.88 0.89 ± 0.09
(p = 0.94)
“Discussion”). We, therefore, examined ethanol-induced changes
in α4 subunit levels within dopaminergic (TH immunoreactive)
inputs to the core/shell of the NAc, ad BLA, LA and CeA of the
amygdala. In the NAc (core + shell), we observed a significant
increase in the total volumetric density of α4-YFP puncta
(Figure 5A, t-test, ∗∗∗∗p < 0.0001) following acute ethanol
administration. This was driven by an increase in the density of
α4-YFP puncta both in the core and the shell (Figure 5B, two-way
ANOVA: [ethanol treatment]: F(1,28) = 33.1, ∗∗∗∗p < 0.0001,
with Sidak’s multiple comparison revealing a significant effect
of ethanol treatment in both the NAc core and shell:
∗∗∗∗p < 0.0001). Interestingly, we observed a similar increase
in the volumetric density of α4-YFP puncta within TH
immunoreactive fibres in the NAc (core + shell) following
acute ethanol administration (Figure 5C, t-test, ∗∗∗∗p< 0.0001).
Similarly, this was the result of an increased density of
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FIGURE 5 | Acute ethanol exposure significantly increases levels of α4 subunit in the nucleus accumbens shell and core. (A,B) Effect of acute ethanol on the
volumetric density of YFP puncta in the NAc (A) or the core and shell (B) subregions. Data are presented as mean puncta density per 103 µm3 of tissue ± SEM. (A:
two-tailed unpaired t-test, ∗∗∗∗p < 0.0001, compared to saline; B: Two-way ANOVA, followed by Sidak post hoc analysis, ∗∗∗∗p < 0.0001, compared to saline).
(C,D) Effect of acute ethanol on the volumetric density of YFP puncta within TH immunoreactive fibres in the NAc (C), or in the core and shell (D) subregions. Data
are expressed as mean puncta density per µm3 of TH immunoreactive fibres ± SEM. (C: two-tailed unpaired t-test, ∗∗∗∗p < 0.0001, compared to saline; D:
Two-way ANOVA, followed by Sidak post hoc analysis, ∗∗∗∗p < 0.0001, compared to saline).
α4-YFP puncta within TH immunoreactive fibres in both the
core and the shell (Figure 5D, two-way ANOVA: [ethanol
treatment]: F(1,62) = 91.267, ∗∗∗∗p < 0.0001, with Sidak’s
multiple comparison revealing a significant effect of ethanol
treatment in both the NAc core and shell, ∗∗∗∗p < 0.0001).
We did not observe any change in the overall density of TH
immunoreactive fibres in the NAc (saline: 484.5 ± 25.0 vs.
ethanol: 497.6 ± 12.4 mm3/103mm3 of tissue, t-test, p = 0.63,
Supplementary Figure S1c).
The total volumetric density of α4-YFP puncta was also
increased in the amygdala (BLA + CeA + LA) (Figure 6A;
t-test, ∗∗∗p = 0.0007), and this was mostly driven by an increase
in α4-YFP puncta density in the BLA (Figure 6B, two-way
ANOVA, [ethanol treatment]: F(1,90) = 3.655, p = 0.0591
with Sidak’s multiple comparison revealing a significant
effect of ethanol treatment in the BLA (∗∗p < 0.002), with
no significant changes in the CeA (p = 0.98) or the LA
(p = 0.97). As a result, the volumetric density of α4-YFP
puncta within TH immunoreactive fibres was also increased
in the overall amygdala (Figure 6C, t-test, ∗∗∗p = 0.007),
resulting principally from an increased α4-YFP puncta density
within TH immunoreactive axons (two-way ANOVA, [ethanol
treatment]: F(1,90) = 5.631, ∗p = 0.0198) located in the BLA
(Sidak’s post-test: ∗∗p = 0.0059), with no change in the LA
(p = 0.93) and the CeA (p = 0.93) (Figure 6D). The density
of TH immunoreactive axons was unchanged in the amygdala
(saline: 219.4 ± 12.56 vs. ethanol: 219.5 ± 20.33 mm3/103mm3
of tissue, t-test: p = 0.10, Supplementary Figure S1d).
As the anti-TH antibody that we used predominantly
labels dopaminergic neurons (Supplementary Figure S2a)
and terminals (Supplementary Figure S2c), compared to
noradrenergic neurons (Supplementary Figure S2b) and
terminals (Supplementary Figure S2d), the reconstructed TH
immunoreactive fibres are likely dopaminergic.
Acute Ethanol Administration Increases
the Distribution of α4 Subunits in
Synaptophysin-Immunoreactive
Presynaptic Boutons within
Dopaminergic Fibres in the NAc Core,
and Shell and BLA
To assess if the upregulation of α4 subunits could have
functional consequences, we determined whether it occurs in
presynaptic boutons within TH axons. For this, we quantified the
proportion of total α4-YFP puncta co-localised with the marker
of presynaptic boutons synaptophysin, in TH-immunoreactive
axons. We observed a significant effect of [ethanol treatment]:
F(1,24) = 108.3, ∗∗∗∗p < 0.001, with Sidak’s post hoc comparison
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FIGURE 6 | Acute ethanol exposure significantly increases levels of α4 subunit in the basolateral amygdala but not the central or lateral amygdala. (A,B) Effect of
acute ethanol on the volumetric density of YFP puncta in the amygdala (A), or the BLA, CeA and LA (B) subregions. Data are presented as mean puncta density per
103 µm3 of tissue ± SEM. (A: two-tailed unpaired t-test, ∗∗∗p < 0.001, compared to saline; B: Two-way ANOVA, followed by Sidak post hoc analysis, ∗∗p < 0.01,
compared to saline). (C,D) Effect of acute ethanol on the volumetric density of YFP puncta within TH immunoreactive fibres in the amygdala (C), or the BLA, CeA
and LA (D) subregions. Data are expressed as mean puncta density per µm3 of TH immunoreactive fibres ± SEM. (C: two-tailed unpaired t-test, ∗∗∗p < 0.001,
compared to saline; D: Two-way ANOVA, followed by Sidak post hoc analysis, ∗∗p < 0.01, compared to saline).
FIGURE 7 | Acute ethanol exposure significantly increases the proportion of synaptic α4-YFP puncta co-localised with the marker of presynaptic boutons,
synaptophysin, within TH-imunoreactive terminals in the nucleus accumbens and basolateral amygdala. (A) Effect of acute ethanol on the co-localisation of YFP
puncta with synaptophysin puncta within TH immunoreactive axons in the NAc core, shell and BLA. Data are presented as a proportion of YFP puncta co-localised
with synaptophysin (SYN) puncta in TH fibres, as a percent of total YFP puncta in TH fibres ± SEM (Two-way ANOVA, followed by Sidak post hoc analysis,
∗∗∗p = 0.0003; ∗∗∗∗p < 0.0001; compared to saline). (B) Effect of acute ethanol on the density of synaptophysin puncta within TH-immunoreactive fibres. Data are
presented as mean density of SYN puncta per µm3 of TH reconstructed fibres ± SEM (Two-way ANOVA, followed by Sidak post hoc analysis, non-significant).
revealing an increased proportion of synaptic α4-YFP puncta
(α4-YFPSYN/TH) in all the subregions analysed (NAc core, NAc
shell and BLA) following acute alcohol treatment (Figure 7A,
∗∗∗p = 0.0003; ∗∗∗∗p < 0.0001). This effect was independent
of changes in the density of synaptophysin boutons within TH-
immunoreactive axons (SYNTH) as there was no significant effect
within [ethanol treatment] factor: F(1,24) = 3.16, p = 0.081.
Sidak’s post hoc comparison revealed no significant effect of
ethanol on the density of SYNTH puncta in each brain region
(Figure 7B, NAc core: p = 0.56; NAc shell: p = 0.59 and
BLA: p = 0.86). Representative micrographs of the effect
of ethanol on the synaptic distribution of α4-YFPSYN/TH
puncta in the NAc and BLA are provided (Figures 8A,B,
respectively), showing that alcohol treatment increases the
proportion of α4-YFPSYN/TH puncta [NAc 16% (saline) vs.
25% (ethanol), Figure 8A; BLA 17% (saline) to 34% (ethanol),
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FIGURE 8 | Representative micrographs showing the ethanol-induced upregulation of α4-YFP puncta within the synaptic boutons of dopaminergic terminals in the
NAc (A) and the BLA (B). The top horizontal panel shows a TH immunolabelled axon (grey), followed by the anti-GFP (YFP) staining of α4 receptor puncta (green)
and synaptophysin puncta (red). The bottom horizontal panel shows the merge of upper panels. White arrowheads show synaptophysin puncta co-localised with
one or more α4 receptor puncta (yellow). Scale bar: 3 µm.
Figure 8B]. Consequently, the proportion of α4-YFPTH puncta
not co-localised with SYN puncta was decreased both in the NAc
[84% (saline) vs. 75% (ethanol)] and the BLA [83% (saline) vs.
66% (ethanol)].
DISCUSSION
In the past, studies examining changes in nAChRs have
used receptor-specific antibodies; however, such analyses raise
questions due to lack of selectivity of the antibodies for
the desired subunit. In this study, we have used α4-YFP
knock-in mice to evaluate whether ethanol exposure affects
the levels of α4 nAChR subunit protein and/or the Chrna4
mRNA that encodes this subunit. This mouse line displays
normal subcellular localisation, ACh-induced currents and ACh-
induced Ca2+ fluxes (Nashmi et al., 2007). We have also
previously used these mice to identify reduced α4∗ nAChR
levels in α5 knock-out mice using western blot (Chatterjee
et al., 2013), with Renda and Nashmi (2014) only recently
using the same strain to characterise an upregulation of α4∗
nAChRs after chronic nicotine pre-treatment using qualitative
measurements of fluorescence intensity. In the present study,
we have adapted a quantitative approach (Belmer et al., 2017)
to demonstrate that synaptic α4∗ nAChRs, in specifically
dopaminergic fibres within the NAc and BLA, are upregulated
just hours after a single ‘binge’ episode of alcohol administration.
For this, we colocalised the α4∗ nAChRs with the presynaptic
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bouton marker synaptophysin in dopaminergic axons using a
high-resolution confocal laser scanning microscopy approach.
Although synaptophysin is a one of the most widely used protein
markers of functional synapses and synaptic plasticity in the
brain, this approach is not resolutive enough to conclude on the
subsynaptic localisation of α4∗ nAChRs and whether they are
located at the synaptic membrane (functional), or located within
the submembrane cytoskeleton (inactive). Pharmacology and
physiology experiments will therefore be needed to determine
whether the alcohol-upregulated α4∗ nAChRs are pharmacology
active and functional.
ACh influences numerous physiological and pathological
processes in the CNS via activation of nAChRs (Albuquerque
et al., 2009) that modulate neurotransmitter release (MacDermott
et al., 1999). The activation of DA receptors can increase
acetylcholine release, (DeBoer et al., 1996; Nicola et al., 2000),
and nAChRs on dopamine terminals play a key role in facilitating
endogenous acetylcholine’s ability to trigger synaptic dopamine
release (Marubio et al., 2003; Mao et al., 2011; Cachope et al.,
2012; Threlfell et al., 2012). This circuit is potentiated by
ethanol, and reduced in mice lacking the α4 subunit (Liu
et al., 2013). Interestingly, the increases in α4∗ nAChRs seen
in the amygdala were comprised solely of changes within the
BLA. St Onge et al. (2012) previously revealed that disruption
in communication between the BLA and NAc biassed choice
toward larger, uncertain rewards on a probabilistic discounting
task in rodents. Importantly, release of dopamine into the BLA
may be distinctly involved in the response to both rewarding
and threatening stimuli (Phillips et al., 2003), and changes in
synaptic nAChRs on dopaminergic terminals may influence
further responses, with damaged dopamine signalling also linked
to several neuropsychiatric disorders (Ledonne and Mercuri,
2017). Many previous studies show that direct interaction of BLA
activity and NAc dopamine is essential to conditioned reward
associations (Ambroggi et al., 2008; Jones et al., 2010) and likely
confers the motivational value of alcohol-related stimuli (Ghods-
Sharifi et al., 2009). Interestingly, while most of the increase
occurred in dopaminergic neurons, a small subset of receptors
was upregulated on non-TH+ fibres. These may comprise
nAChRs on GABAergic interneurons or serotonergic terminals,
with conflicting reports of presynaptic nAChR modulation of
ACh release from cholinergic axons (Schwartz et al., 1984;
Pradhan et al., 2002; Quik and Wonnacott, 2011).
Current research indicates that nAChR subunit genes are
potential contributors to the development of both alcoholism and
tobacco abuse (Schlaepfer et al., 2008; Hoft et al., 2009a,b; Zuo
et al., 2016). Also, SNP analysis of CHRNA4 by Tritto et al. (2001)
and Feng et al. (2004), demonstrated that two SNPs are associated
with a protective effect against nicotine and alcohol addiction in
humans and mice (Tritto et al., 2001; Feng et al., 2004) when
exposed chronically. Combined with the results reported here, it
is likely that while polymorphisms of the CHRNA4 gene play a
role in altering the sensitivity of the subunit to ethanol (Butt et al.,
2003; Coon et al., 2014), acute doses of ethanol do not influence
transcription.
Previous studies in this area are few and have produced mixed
results. An early study on chronic ethanol exposure showed
an increase in α4 mRNA levels of 22% after 4 days of direct
application of ethanol to neuronal cell culture (Gorbounova
et al., 1998). A recent study, and the only found addressing
acute ethanol exposure reported no change in α4 mRNA
expression after 24 h of application in foetal neural progenitor
cells (Balaraman et al., 2012). Interestingly, the same study
found a decrease in nAChR subunit mRNAs in a longer
term of application (5 days). An in vivo study on nicotine
reported a drop in the level of CHRNA4 gene expression in
the VTA and an increased expression in the NAc in rat pups
after 4 weeks of gestational exposure (Chen et al., 2005). It
could be suggested that α4 mRNA levels may be altered only
in long-term ethanol consumption, and possibly be limited
to distinct developmental periods such as prenatal. As for
protein expression, a previous ligand binding study reported
an increase in α4β2 nAChRs in M10 cells exposed to ethanol
after 48 h, which remained elevated for as long as 6 days
after removal of the drug (Dohrman and Reiter, 2003). While
not only being a study using cell culture, the cells specifically
expressed only α4β2 nAChRs and was a purely in vitro model.
In the mammalian brain, α4 nAChR subunits may also form
receptors with the α5 nAChR subunit, which plays a distinct
role in driving the expression of α4∗ receptors (Chatterjee et al.,
2013), making the in vivo study of ethanol on α4∗ receptors
valuable.
Studies that have focused on the function of nAChRs have
demonstrated that deleting the α4 nAChR subunit caused
increased sensitivity to nicotine-induced locomotor depression
and decreased sensitivity to anxiolytic effects (McGranahan
et al., 2011), suggesting an involvement of the amygdala. In
addition, other groups showed that α4-knockout (KO) mice did
not systemically self-administer nicotine and displayed a lack
of nicotine-induced dopamine level increase seen in WT mice
exposed to nicotine (Marubio et al., 2003; Pons et al., 2008).
Similar observations were made in relation to alcohol addiction,
as ethanol-induced place preference was absent in α4KO mice
and was increased in mice with a single point mutation producing
hypersensitive α4∗ nAChRs (Liu et al., 2013). This suggests that
the α4 subunit is necessary for the development of alcohol and
nicotine dependence and increased levels of the subunit will affect
susceptibility to addiction.
As discussed previously, we do not know the subcellular
mechanism underlying the ethanol-induced increase in α4∗
nAChR levels. Because we did not see a change in local mRNA
expression, ethanol-induced upregulation, like nicotine-induced
upregulation, is a post-translational mechanism. Amongst the
possible mechanisms, we believe that two particular post-
translational mechanisms are unlikely to occur. First, although an
increase in NAc dopamine could augment acetylcholine (ACh)
levels, and this could, in turn, lead to desensitisation of α4β2
nAChRs, desensitisation does not appear to cause upregulation
(Henderson and Lester, 2015). Second, in neurons, nicotine
does not affect the rate of nAChR endocytosis from the plasma
membrane (Henderson and Lester, 2015).
Upregulation of nAChRs by chronic exposure to nicotine,
at smoking-relevant concentrations, is selective at every level
explored to date. Some evidence supports the hypothesis that
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this selective upregulation is necessary and sufficient for the early
stages of nicotine dependence (Miwa et al., 2011; Henderson
and Lester, 2015; Henderson et al., 2017). Here we describe
these tiers of selectivity. At the level of brain regions, nicotine
upregulates nAChRs in hippocampus, cortex, amygdala (Le Foll
et al., 2016) and midbrain; but not in the thalamus. Among
cell types within brain regions, nicotine upregulates nAChRs
strongly in the somata of VTA GABAergic neurons, but only
modestly in the somata of VTA dopaminergic neurons. There is
also selectivity at the level of somatodendritic vs. axon terminal
regions: in dopaminergic neurons, upregulation is modest in the
somatodendritic region, but strong in the axon terminals, as
also found for binge ethanol in the present study. At the level
of nAChR composition, selectivity is also observed: the most
consistently upregulated receptors are α4β2∗ (where the asterisk
denotes the possible presence of other subunits). In some regions,
α6β2∗ nAChRs are also upregulated. Other nAChR subtypes
are upregulated only by much higher, non-pharmacologically
relevant nicotine doses. The combinations thought to be
resistant to upregulation include α4β4, α4β3, and α7. There
is also selectivity at the level of subunit stoichiometry within
a nAChR pentamer: (α4)2(β2)3, but not (α4)3(β2)2, nAChRs
are upregulated by chronic exposure to nicotine. Although no
single molecular or molecular level mechanism accounts for these
tiers of selectivity, in most cases the upregulated nAChRs are
(α4)2(β2)3. These (α4)2(β2)3 nAChRs are constitutively retained
to some extent in the endoplasmic reticulum (ER) and cis-
Golgi (Kuryatov et al., 2005; Sallette et al., 2005) and also bind
nicotine rather strongly at smoking-relevant doses. Nicotine
enters the ER, acts as a stabilising pharmacological chaperone,
protects nAChRs against ER-associated degradation (ERAD),
and enhances exit of nAChRs from the ER, thus enhancing
the number which eventually reach the plasma membrane. This
post-translational pharmacological chaperoning is the dominant
mechanism of nicotine-mediated upregulation (Henderson and
Lester, 2015).
In contrast, a more likely mechanism for ethanol-induced
upregulation derives from recent experiments showing that >24
hr exposure to menthol upregulates α4β2∗ nAChRs, both in the
absence and presence of nicotine. This upregulation may be an
example of chemical chaperoning: the menthol binds to as-yet
undetermined non-agonist sites, either on the nAChR or on
other components of the pathway taken by nAChRs to exit the
ER (Henderson et al., 2016, 2017). We suggest that a binge of
ethanol acts via a similar mechanism(s). Ethanol increases the
open channel state of nAChRs (Wu and Miller, 1994; Forman
and Zhou, 1999; Zuo et al., 2004), and this increased stability,
if it also occurs in the ER, may protect nAChRs against ERAD.
The rather general mechanism of chemical chaperoning should
be distinguished from specific pharmacological chaperoning
(Kuryatov et al., 2005; Henderson and Lester, 2015), which
also occurs within the ER but involves the binding of nicotine
or other agonists to nAChRs themselves, at or very near the
ACh binding site within the interface between the α4 and β2
subunits.
An identifiable aspect of alcohol use is its strong correlation
with nicotine use, and α4∗ nAChRs in reward areas of the
brain are likely involved in the co-morbidity of these two drugs
(Liu et al., 2013), for a comprehensive review see (Tarren and
Bartlett, 2017). In line with this, advances in pharmacotherapy
for AUDs have indicated the potential of various α4β2∗ nAChR
agonists such as the smoking cessation drugs cytisine and
varenicline in reducing ethanol self-administration (Steensland
et al., 2007; Hendrickson et al., 2010; Bito-Onon et al., 2011;
Mitchell et al., 2012). Increases in α4∗ nAChRs seen after just
a single dose of ethanol may then both increase propensity
for nicotine use, as well as increase the efficacy of α4∗
nAChR targeted therapies for reducing co-morbid alcohol and
nicotine use.
CONCLUSION
The work presented here not only identifies acute changes
to a major population of nAChRs caused by an intoxicating
dose of alcohol, but also for the first time visualises specific
neuronal populations involved in α4∗ nAChR-mediated alcohol
behaviours. Whether similar changes occur following a moderate
dose of alcohol and/or after chronic exposure, however, was not
elucidated in the present work.
If upregulation of α4 containing nAChRs by ethanol does not
involve new protein synthesis, it is believed this process may
be contingent on post-translational events, and likely has far-
reaching implications (Henderson and Lester, 2015). In addition,
whether this process impacts long-term alcohol consumption and
seeking remains to be investigated.
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FIGURE S1 | Tyrosine hydroxylase expression following acute ethanol exposure in
the nucleus accumbens and amygdala. (a,b) Quantification of TH levels by
Western Blot analysis shows no effect of ethanol in the NAc (a) or the Amg (b).
Data are presented as mean k counts for TH expressed as a percentage of
GAPDH k counts ± SEM (two-tailed unpaired t-test, a: NAc: p = 0.30, n = 4; and
b: Amg: p = 0.55, n = 7–8). (c,d) Quantitative immunohistochemistry confirmed
the absence of change in TH expression in the NAc (c) and the Amg (d). Data are
presented as mean volumetric density of fibres in µm3 per 103 µm3 of tissue
(two-tailed unpaired t-test, c: NAc: p = 0.62; and d: Amg: p = 0.99, compared to
saline).
FIGURE S2 | Immunohistochemistry against TH labels more the dopaminergic
neurons and terminals than the noradrenergic neurons and terminals. (a,b)
Immunolabelling of TH-immunoreactive dopamine (DA) neurons in the ventral
tegmental area (VTA, a) and TH-immunoreactive noradrenergic (NA) neurons in the
locus coeruleus (LC, b). (c,d) Immunolabelling of TH-immunoreactive terminals in
DA terminal-rich region, the NAc (c) and NA terminal-rich region, the
paraventricular nucleus (PVN, d). Scale bar: 50 µm.
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